Odyssey Therapeutics, Inc. ODTX
19.36 USD -0.02 (-0.08%)
As ofNov 18, 2026, 2:11 PM EST
19.13 Day range 19.98
15.10 52-week range 29.05
- YTD
- +17.87%
- 1 year
- +17.87%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
| 2.98M | 4.47M | |
| 2.98M | 4.47M | |
| -161.16M | -135.22M | |
| -148.65M | -130.40M | |
| -48.93 | -148.21 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
| 41.69M | 59.14M | |
| 269.79M | 197.44M | |
| 54.51M | 65.07M | |
| 27.11M | 31.01M | |
| -488.28M | -382.53M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
| -129.47M | -117.47M | |
| -103.94M | 96.78M | |
| 215.65M | 26.98M | |
| -875.00K | -764.00K | |
| -17.45M | 6.34M |
